Patricia Drake
Corporate Officer/Principal at TREVENA, INC.
Net worth: 43 795 $ as of 29/04/2024
Profile
Patricia Drake is currently the Chief Commercial Officer & Senior Vice President at Trevena, Inc. Prior to this, she was the Chief Executive Officer & Managing Director at MSD Finland Oy from 2019 to 2021, and the Chief Commercial Officer at Sesen Bio, Inc. in 2021.
She completed her undergraduate degree at Wichita State University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
TREVENA, INC.
0.58% | 13/12/2023 | 107,078 ( 0.58% ) | 43 795 $ | 29/04/2024 |
Patricia Drake active positions
| Companies | Position | Start |
|---|---|---|
| TREVENA, INC. | Corporate Officer/Principal | 10/11/2021 |
Former positions of Patricia Drake
| Companies | Position | End |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Corporate Officer/Principal | 31/08/2021 |
| MSD Finland Oy | Chief Executive Officer | 30/04/2021 |
Training of Patricia Drake
| Wichita State University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| TREVENA, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Sesen Bio, Inc.
 Sesen Bio, Inc. Pharmaceuticals: MajorHealth Technology Sesen Bio, Inc. is a late-stage clinical company, which engages in the development of targeted fusion protein therapeutics. It offers Vicineum and Proxinium, which target tumor cell surface antigens that allow for rapid internalization into the targeted cancer cell and also have limited expression on normal cells. The company was founded by Reza Dana, K. Christopher Garcia, Gregory L. Verdine, Casey T. Weaver, and K. Dane Wittrup on February 25, 2008 and is headquartered in Cambridge, MA. | Health Technology |
| MSD Finland Oy |
- Stock Market
- Insiders
- Patricia Drake
